Valneva SE (VALN) Beginning Cash Balance (2021 - 2024)
Valneva SE (VALN) posted Beginning Cash Balance of $307.5 million for Q1 2023, down 20.95% sequentially from $389.0 million in Q1 2022, and down 20.95% YoY from $389.0 million in Q1 2022.
Powered by 
Analysis
Valneva SE (VALN) Beginning Cash Balance (2021 - 2024) Analysis & Trends
Valneva SE has reported Beginning Cash Balance for 3 years, with the latest figure at $307.5 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 134.73 Mn |
| Dec 31, 2023 | 308.29 Mn |
| Sep 30, 2023 | 311.92 Mn |
| Jun 30, 2023 | 312.01 Mn |
| Dec 31, 2022 | 353.66 Mn |
| Sep 30, 2022 | 349.51 Mn |
| Jun 30, 2022 | 369.89 Mn |
| Jun 30, 2021 | 246.15 Mn |